The FDA advisory panel unanimously supported mRNA-1010/mFLUSIVA for adults 50–64 and 65+, and the stock is already reacting ...

Automations are greater than ever.

Cloudflare is making AI crawler blocking the default for many websites while introducing new controls and payment models for ...

KALA BIO, Inc. (NASDAQ: KALA) (“Kala” or the “Company”) today announced the initial commercial deployment of the Bionic Intelligence Research Agent (BIRA), the Company's first purpose-built agentic AI ...

The seven companies listed here cover the realistic range of what a buyer will encounter in 2026: embedded ML teams that own ...

Firefighters, health officials and water safety advocates share tips for staying safe over the holiday weekend and summer.

As energy companies push AI deeper into industrial operations, success increasingly depends on governance, trusted data, and ...

TSS's cash-rich balance sheet and high-margin growth justify a valuation premium for risk-tolerant investors. Check out why TSSI stock is a buy.

Director Antonio Viana sold 20,839 shares for a total transaction value of approximately ~$761,000 based on a weighted average sale price of $36.51 per share as of June 4, 2026. This transaction ...